News - PharmaNL

Innovation in action: video National Growth Fund

December 9, 2025

What does PharmaNL actually stand for? In this short video, produced by the National Growth Fund, Board Member Ton Vries explains how we connect knowledge institutions, companies, and start-ups. This collaboration helps innovative medicines and production technologies move faster from idea to production. By investing in R&D infrastructure and training, we position the Netherlands as […]

Eight National Growth Fund initiatives join forces to strengthen the Dutch Life Sciences & Health ecosystem

December 4, 2025

Eight initiatives funded through the Dutch National Growth Fund are joining forces to accelerate Life Sciences & Health innovation and sustainable economic growth, with a focus on societal impact in The Netherlands. On December 2, representatives of Biotech Booster, Health-RI, HOLOmicrobiome, NXTGEN Hightech, Ombion, Oncode Accelerator, PharmaNL and RegMed XB officially signed a Memorandum of Understanding […]

Impact Series 6: ACESO. Innovation in screening infrastructure

November 27, 2025

The ACESO project is central in this sixth edition of the PharmaNL Impact Series. In this series, we spotlight a different project each time that, with the support of PharmaNL and made possible by ZonMw, contributes to the future of the Dutch pharmaceutical sector. What are the first results, what challenges are there, and what […]

Funded Projects in the Human Capital Growth 2024 Funding Round

October 30, 2025

Good news: six new projects have been awarded funding within the PharmaNL Human Capital Growth (HCG) program line. These projects specifically focus on developing flexible post-secondary, post-bachelor, and post-graduate education tailored to the evolving needs of the pharmaceutical sector. The PharmaNL Human Capital Growth 2024 call marks the second funding round within the HCG program […]

Impact Series Episode 5: Groningen Human Capital for Life Sciences. Training program gives professionals an edge in bioanalysis and gene technology

September 4, 2025

In the PharmaNL Impact Series, we show how innovative projects come to life thanks to PharmaNL funding: what first results have been achieved, what challenges arise, and what lessons they offer to others. In this fifth episode, the spotlight is on the Groningen Human Capital for Life Sciences project, led by the LIFE Cooperative together […]

Impact Series 4: Early Drug Discovery Education Track. Future-proof training for pharma professionals

July 7, 2025

“The pharmaceutical industry is evolving at lightning speed. If we don’t continuously upskill our professionals, they’ll fall behind, and that will negatively impact the entire sector.” With this clear message, Adinda Diekstra, Programme Manager for Post-Bachelor Courses & Training at HAN University of Applied Sciences, underscores the importance of the Early Drug Discovery Education Track […]

Impact Series 3: Nanoworx. Smart Optimization for Scale-Up Makes the Difference

June 25, 2025

In the PharmaNL Impact Series, we spotlight innovative projects that have taken off thanks to funding from PharmaNL. What are the initial results? What challenges have emerged? And what can others learn from these experiences? In this third episode, we take a closer look at Nanoworx, a promising initiative within the PharmaNL program line Shared […]

Impact Series 2: iPsomics. From Academic Innovation to Personalized Cancer Treatment

June 19, 2025

The PharmaNL Impact Series showcases real-life examples of how PharmaNL projects are progressing. What early results are emerging, what challenges are being faced, and what lessons can others take from them? In this second episode, we caught up with Peter Ketelaar and Floris Foijer of iPsomics, a promising life science start-up born out of the […]

English Translation of Investment Agenda Part 3 Now Available

June 12, 2025

The English translation of PharmaNL Investment Agenda Part 3 is now available. This document, part of the agenda presented on 22 August 2024, focuses on the Shared Development Infrastructure programme line. The Investment Agenda serves as a roadmap for targeted investments aimed at strengthening the Dutch pharmaceutical value chain.

Impact Series 1: Future-oriented education for biomedical and pharmaceutical professionals

June 10, 2025

PharmaNL Impact Series – Updates on ongoing projects and their impact In the PharmaNL Impact Series, we provide insights into projects that have recently commenced under PharmaNL’s two program lines: Human Capital Growth and Shared Development Infrastructure. Each article focuses on one project: its objectives, progress made so far, challenges faced by the teams, and […]